N19 N00-N08 N10-N16 N17-N19 N20-N23 N25-N29 N30-N39
Conditions
Interventions
Group 1: Patients with moderate kidney insufficiency will be interviewed biannually on disease history, disease course, health behavior, quality of Life and complications
a physical exam will be performed and serum, plasma and urine samples will be collected
at the beginning DNA is collected for genetic analyses. There will be no intervention with the therapeutic regime.
Sponsors
Medizinische Klinik 4 (Nephrologie und Hypertensiologie),
Eligibility
Sex/Gender
All
Age
18 Years to 74 Years
Inclusion criteria
Inclusion criteria: eGFR:30-60 ml/min/1,73 m² OR: eGFR >60 ml/min/1,73 m² AND: Proteinuria (Albuminuria > 300 mg/Tag OR: total protein > 500 mg/Tag)
Exclusion criteria
Exclusion criteria: non caucasian origin, solid organ transplantation, active malignancy within 2 years prior to inclusion, heart insufficiency NYHA IV, unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| all cause mortality, myocardial infarction, end stage renal disease, halfing of eGFR | — |
Secondary
| Measure | Time frame |
|---|---|
| Stroke, Procedure of revascularisation in PAD, Hospitalization | — |
Countries
Germany
Contacts
Public ContactStephanie Titze
Medizinische Klinik 4 (Nephrologie und Hypertensiologie), Universitätsklinikum Erlangen
Outcome results
None listed